We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.45 | -10.91% | 3.675 | 3.50 | 3.85 | 4.125 | 3.675 | 4.13 | 424,106 | 11:58:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.90 | 26.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2024 11:02 | Everyone tip toes around forward looking statements. Well we've had the first quarter . Was it good?I think Smith is smart considered and is strategically on course . The but concerns Adrenalin . Could he not have a double espresso before one of his media opportunities? Atb folks | alchemy | |
09/5/2024 10:56 | 'Maybe it’s being set up for being beaten' Smashed more likely imo. | supersonico | |
09/5/2024 10:46 | That's your view and thanks for your patience in typing it out. Sales, Margin, Overheads, and Cash are the key parameters and yes Sales leads the pack, Sorry to bang the same drum but the estimate of only £5mill for 24 is disappointing. Maybe it's being set up for being beaten. Deja vu of previously deja viewed is my current concern | alchemy | |
09/5/2024 10:35 | Nice to see this Syngenta fella supporting the Supersonico Wild guesses by being the first to like the planned Eden PR on Linked-in. Humair Tariq Portfolio Manager Biologicals, Insect Control and Seed Treatment Results & Data-Driven Marketing Expert | Global Portfolio Management @ Syngenta I Catapulting Businesses to New Heights | Unmatched NPI Prowess I Mastering Digital Capabilities I Entrepreneur I Founder@Barbell Studioz Syngenta 11 yrs 8 On-site Portfolio Manager Biologicals, Insect Control and Seed TreatmentPortfolio Manager Biologicals, Insect Control and Seed Treatment Full-timeFull-time May 2022 - Mar 2024 · 1 yr 11 mosMay 2022 to Mar 2024 · 1 yr 11 mos United KingdomUnited Kingdom Introduced Nuello® iN, Syngenta's inaugural biological seed treatment, resulting in an additional business of £0.6 m. Initiated and primed the portfolio pipeline, ensuring the introduction of 2 products / year until 2026 to expand portfolio range. Leveraged end-to-end NPI for the successful launch of Vixeran®, a foliar bacterial endophyte, adding £1 m to business. Successfully managed PLCM of portfolio by introducing fighter brands to maintain 41% market share. Effectively deterred generic market entry in cereal seed treatment through strategic pricing and commercial incentives. Established a technical asset library for NUE technologies, utilized by the sales team for capability development. Managed CRD and HCP collaboration for EA of CP & ST products, yielding GBP 0.3 million in additional revenue. Brought campaign efficiencies and cost savings by taking data-driven decisions using Remote Sensing Technologies and GIS system. | supersonico | |
09/5/2024 10:30 | Not if you have seen his posts for the last few years. He always seems to have a bit of inside info, but only of the positive spin kind. In the meantime Eden has cratered. Tricky by name tricky by nature. | ravenna23 | |
09/5/2024 09:50 | That's a bit steep. | alchemy | |
09/5/2024 09:33 | Tricky, you are as full of BS as the directors. The CEO and CFO are so delusional that they believe their presentation will shore up the price. Hilarious. There is only one thing that will stop the rot and that is actual volume sales. Still no sign of that. I'm sure that everyone who contributed to the latest capital raising is ecstatic with the company's performance. Go back to your boiler room you shameful toad. | ravenna23 | |
09/5/2024 09:17 | Proactive video released today | investingisatrickygame | |
09/5/2024 09:02 | Yes I don't want confirmation of the route confirmation again. | alchemy | |
09/5/2024 07:08 | I hope between now and then that they have something else to add to the mix as if not this looks imo like a waste of time given what is publicly available in the PR they have already done over the last year. Investor Presentation via Investor Meet Company. | supersonico | |
09/5/2024 06:29 | "Any thoughts on what the up front / milestone pre sales payments might look like given the NDA'S in place prior to announcement?" They have never been that significant, have they? | investingisatrickygame | |
08/5/2024 22:20 | Any thoughts on what the up front / milestone pre sales payments might look like given the NDA'S in place prior to announcement? | supersonico | |
08/5/2024 14:52 | What multiple of market size is insecticide against our current target markets ? | alchemy | |
08/5/2024 12:59 | Alchemy: Someone as MIND-NUMBINGLY THICK as you shouldn't be anywhere near the stockmarket. Even "remotely near"! I feel physically unclean to be on the same forum as morons like you and Timbo_Slice. Please show this message to your handler. | neutralpov | |
08/5/2024 11:18 | 1.1 million in half year 23 - announced late September ! Sainthood awaits us all . | alchemy | |
08/5/2024 11:12 | Views on FY 24 turnover. Cavendish at 5 millionModest or not?Next data point on revenue half year results . So August ? And paraphrasing Invrstor what will start the jazz concert ? Cos it's monotone white noise at the moment | alchemy | |
08/5/2024 10:14 | Investingisatrickyga [[ SNIP!! ]] FOAD, perv. You think we don't know about your addiction? And I don't mean the kiddiepron. | neutralpov | |
08/5/2024 09:27 | MW retired and closed site down. | babysitter | |
08/5/2024 09:24 | Eden needs appetite for its shares, something that is sadly lacking and frankly, has been for years. That is undeniable. Michael Walters, strong supporter of Eden that he was/is, is not going to propel the share price forward. New actions are needed to resonate with the investor community. | investingisatrickygame | |
08/5/2024 08:41 | What's happened to Michael Walters? | sandcrab2 | |
07/5/2024 19:38 | I have read the Cavendish note.Like the content of the RNS I think it's a "route confirmation" note.I was disappointed that Cavendish is thinking £5million for FY24.3:2 to 5 following 1.8 to 3.2.1.8 delta plays 1.4 and , given new products and new markets, that seems an easy stretch to me.More pebbles needed into the pool. A big pebble would be insecticide causing a big splash.The splash in revenue not til FY 25? But discountable? | alchemy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions